糖尿病と併存する骨粗しょう症の診断と管理(2026年改訂版)
[Diagnosis and management of diabetes and co-existing osteoporosis (Update 2026)].
Muschitz Christian, Kautzky-Willer Alexandra, Rauner Martina, Winhöfer-Stöckl Yvonne ほか — Wiener klinische Wochenschrift
AI要約
糖尿病と骨粗しょう症は高齢者で併発し、骨折リスクを高めます。FRAXや骨密度測定などの評価ツールは糖尿病患者で調整が必要です。治療は、ビタミンDとカルシウムの最適化、骨に悪影響のある糖尿病薬の回避、脆弱性骨折には骨吸収抑制薬等による長期治療を国のガイドラインに基づき行います。
AI生成の要約です — 原文を読む
Abstract(原文)
Diabetes mellitus and osteoporosis are among the most frequent chronic diseases and therefore often occur in one and the same individual. As the prevalence of both diseases increases with age, in view of the age structure of our population their frequency will increase. Patients with diabetes have an elevated risk of fragility fractures. The pathophysiology is unclear and presumably multifactorial. Longitudinal studies have shown that the Fracture Risk Assessment Tool (FRAX) and the bone mineral density (BMD) measured by dual energy X‑ray absorptiometry (DXA, T‑score) and a possibly present trabecular bone score (TBS) can predict the individual risk of fractures; however, an adjustment must be made in order not to underestimate the risk. From an osteological perspective an optimal approach is not yet available as there are no studies with patients who have only diabetes and osteoporosis. Patients with diabetes mellitus and an elevated risk of fractures should be treated in exactly the same way as patients with an increased risk of fractures but without diabetes. The vitamin D level should in every case always be optimized and a sufficient calcium intake should be ensured (preferably via the nutrition). In the selection of the antihyperglycemic treatment, substances with a proven negative effect on bones should be omitted. In the case of a fragility fracture a long-term specific osteological treatment is indicated, independent of all available findings. Antiresorptive medications are the first choice for prevention of fragility fractures and also anabolic drugs according to national reimbursement criteria. Monitoring of treatment should be carried out in compliance with the national osteoporosis guidelines (revised version Autumn 2024).
このコラムに関連する書籍
骨を強くする食事と生活習慣――骨粗鬆症を予防する科学的アプローチ
骨代謝・栄養学関連書籍
カルシウムとビタミンDの相乗効果、骨密度を維持するための食習慣を科学的に解説。
Amazonで本を見るカルシウムが摂れる毎日の食事術
管理栄養士監修
乳製品に頼らずカルシウムを摂る方法を小魚・海藻・大豆製品のレシピで紹介。
Amazonで本を見るAmazonのアソシエイトとして、栄養DBは適格販売により収入を得ています。
出典: PubMed (PMID: 42162486)。AI要約は情報提供のみを目的とし、医療的アドバイスを構成するものではありません。